Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter L Collins

Showing results (221-230 of 247) with videos related to

Pageof 25
Sort By:
Plos Pathogens|December 8, 2016
Actin-Related Protein 2 (ARP2) and Virus-Induced Filopodia Facilitate Human Respiratory Syncytial Virus SpreadMasfique Mehedi, Thomas McCarty, Scott E Martin, et al.
Vaccine|July 31, 2007
Recombinant human parainfluenza virus type 2 vaccine candidates containing a 3' genomic promoter mutation and L polymerase mutations are attenuated and protective in non-human primatesSheila M Nolan, Mario H Skiadopoulos, Konrad Bradley, et al.
American Journal of Respiratory and Critical Care Medicine|September 2, 2020
Live-attenuated Vaccines Prevent Respiratory Syncytial Virus-associated Illness in Young ChildrenRuth A Karron, Jessica E Atwell, Elizabeth J McFarland, et al.
The Journal of Experimental Medicine|September 18, 2002
A role for immune complexes in enhanced respiratory syncytial virus diseaseFernando P Polack, Michael N Teng, Peter L Collins, et al.
Virology|July 30, 2010
Recombinant human parainfluenza virus type 2 with mutations in V that permit cellular interferon signaling are not attenuated in non-human primatesAnne Schaap-Nutt, Christopher D'Angelo, Emerito Amaro-Carambot, et al.
Journal of Virology|February 13, 2009
A chimeric A2 strain of respiratory syncytial virus (RSV) with the fusion protein of RSV strain line 19 exhibits enhanced viral load, mucus, and airway dysfunctionMartin L Moore, Michael H Chi, Cindy Luongo, et al.
Journal of Virology|April 28, 2006
Alpha and lambda interferon together mediate suppression of CD4 T cells induced by respiratory syncytial virusBo Chi, Harold L Dickensheets, Kirsten M Spann, et al.
Virology|February 4, 2017
Respiratory syncytial virus infection induces a subset of types I and III interferons in human dendritic cellsPhilippa Hillyer, Viraj P Mane, Aaron Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 16, 2005
The cysteine-rich region of respiratory syncytial virus attachment protein inhibits innate immunity elicited by the virus and endotoxinFernando P Polack, Pablo M Irusta, Scott J Hoffman, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2017
Genetic stability of genome-scale deoptimized RNA virus vaccine candidates under selective pressureCyril Le Nouën, Thomas McCarty, Michael Brown, et al.
Pageof 25

Showing results (221-230 of 247) with videos related to

Sort By:
Pageof 25
Plos Pathogens|December 8, 2016
Actin-Related Protein 2 (ARP2) and Virus-Induced Filopodia Facilitate Human Respiratory Syncytial Virus SpreadMasfique Mehedi, Thomas McCarty, Scott E Martin, et al.
Vaccine|July 31, 2007
Recombinant human parainfluenza virus type 2 vaccine candidates containing a 3' genomic promoter mutation and L polymerase mutations are attenuated and protective in non-human primatesSheila M Nolan, Mario H Skiadopoulos, Konrad Bradley, et al.
American Journal of Respiratory and Critical Care Medicine|September 2, 2020
Live-attenuated Vaccines Prevent Respiratory Syncytial Virus-associated Illness in Young ChildrenRuth A Karron, Jessica E Atwell, Elizabeth J McFarland, et al.
The Journal of Experimental Medicine|September 18, 2002
A role for immune complexes in enhanced respiratory syncytial virus diseaseFernando P Polack, Michael N Teng, Peter L Collins, et al.
Virology|July 30, 2010
Recombinant human parainfluenza virus type 2 with mutations in V that permit cellular interferon signaling are not attenuated in non-human primatesAnne Schaap-Nutt, Christopher D'Angelo, Emerito Amaro-Carambot, et al.
Journal of Virology|February 13, 2009
A chimeric A2 strain of respiratory syncytial virus (RSV) with the fusion protein of RSV strain line 19 exhibits enhanced viral load, mucus, and airway dysfunctionMartin L Moore, Michael H Chi, Cindy Luongo, et al.
Journal of Virology|April 28, 2006
Alpha and lambda interferon together mediate suppression of CD4 T cells induced by respiratory syncytial virusBo Chi, Harold L Dickensheets, Kirsten M Spann, et al.
Virology|February 4, 2017
Respiratory syncytial virus infection induces a subset of types I and III interferons in human dendritic cellsPhilippa Hillyer, Viraj P Mane, Aaron Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 16, 2005
The cysteine-rich region of respiratory syncytial virus attachment protein inhibits innate immunity elicited by the virus and endotoxinFernando P Polack, Pablo M Irusta, Scott J Hoffman, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2017
Genetic stability of genome-scale deoptimized RNA virus vaccine candidates under selective pressureCyril Le Nouën, Thomas McCarty, Michael Brown, et al.
Pageof 25